QRLBIO004
The cornea is the transparent tissue that covers the front of the eye. It works with the lens of the eye to focus images on the retina for clear vision. Corneal damage can occur due to various reasons such as Eye injuries (burns, scratches, lacerations), dryness in eyes and infections. This condition can lead to loss of vision and development of cataract. Current treatment of corneal damage is corneal transplant. Currently, only 25,000 corneal transplants are done while the need is 100,000 in India. There is a need for developing advanced therapies for treating corneal damage. QRL is developing an autologous cell-based therapy-QRLBIO004 for treating corneal damage.
ABOUT US
QRL Bioscience has developed Autologous Advanced Biologics (AAB) platform to develop novel therapeutics for treating chronic degenerative diseases such as chronic wounds and osteoarthritis.
LINKS
CONTACT US
Plot No. E7+E8/13, First Floor, GIDC Electronic Estate, Sector 26, Gandhinagar - 382023
+919879514046
info.qrlbioscience@gmail.com
Copyright © 2024 QRL Bioscience Private Limited. All rights reserved.
Designed & Developed By : UiX Studios LLP